Voyageur Pharmaceuticals has engaged Red Cloud Securities to provide market stabilization and liquidity services for its shares on the TSX Venture Exchange. This partnership aims to improve trading liquidity and maintain a reasonable market for Voyageur's common shares. Voyageur focuses on developing pharmaceutical-grade barium and iodine contrast media for medical imaging, with plans to become a vertically integrated manufacturer. The agreement with Red Cloud is ongoing, with a monthly fee and no performance-based compensation, reflecting a strategic move to support the company's market presence and growth potential.
Regions Financial Corporation's stock surged to a 52-week high of $32.47 following a Jefferies analyst upgrade raising the price target to $32. The bank reported strong Q2 2026 adjusted earnings of $0.68 per share, beating estimates of $0.64, driven ...
Several key stocks fell significantly due to company-specific issues. Intuitive Surgical's shares dropped 14.15% despite strong earnings because of slower growth in surgical procedures, impacting related leveraged ETFs. REGENXBIO's stock fell 11.7% a...
DBV Technologies has filed a prospectus with the U.S. SEC to renew its At-The-Market (ATM) offering program, allowing it to raise up to $150 million by selling American Depositary Shares (ADSs). The funds will primarily support expanding manufacturin...
Glencore has amended and restated its $5 million convertible loan agreement with Tantalex Lithium Resources Corporation, splitting the loan into three facilities with adjusted terms and interest rates. The amended agreement includes a 1% gross revenu...
A Race Against Blindness, an Arizona nonprofit, has launched its first electric vehicle fundraiser featuring a 2025 Volkswagen ID. Buzz and $20,000 cash as the grand prize. Running from July 13 to 26, the campaign aims to raise funds for clinical tri...
